A detailed history of Fmr LLC transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Fmr LLC holds 2,092,686 shares of VOR stock, worth $61.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,092,686
Previous 6,422,496 67.42%
Holding current value
$61.3 Million
Previous $4.62 Million 26.69%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$0.15 - $1.62 $649,471 - $7.01 Million
-4,329,810 Reduced 67.42%
2,092,686 $3.39 Million
Q1 2025

May 12, 2025

BUY
$0.72 - $1.74 $2,061 - $4,981
2,863 Added 0.04%
6,422,496 $4.62 Million
Q4 2024

Feb 13, 2025

SELL
$0.64 - $1.27 $416,945 - $827,375
-651,477 Reduced 9.21%
6,419,633 $7.13 Million
Q3 2024

Nov 13, 2024

SELL
$0.7 - $1.1 $3,284 - $5,161
-4,692 Reduced 0.07%
7,071,110 $4.95 Million
Q2 2024

Aug 13, 2024

SELL
$1.0 - $2.2 $532,637 - $1.17 Million
-532,637 Reduced 7.0%
7,075,802 $7.08 Million
Q1 2024

May 13, 2024

SELL
$1.8 - $2.85 $18,916 - $29,950
-10,509 Reduced 0.14%
7,608,439 $18 Million
Q4 2023

Feb 13, 2024

SELL
$1.66 - $2.63 $53,498 - $84,759
-32,228 Reduced 0.42%
7,618,948 $17.1 Million
Q3 2023

Nov 13, 2023

SELL
$2.1 - $3.35 $77,723 - $123,986
-37,011 Reduced 0.48%
7,651,176 $16.2 Million
Q2 2023

Aug 11, 2023

SELL
$3.09 - $5.33 $385,783 - $665,445
-124,849 Reduced 1.6%
7,688,187 $23.8 Million
Q1 2023

May 11, 2023

SELL
$4.68 - $6.96 $736,983 - $1.1 Million
-157,475 Reduced 1.98%
7,813,036 $42 Million
Q4 2022

Feb 13, 2023

BUY
$3.77 - $7.43 $18.1 Million - $35.6 Million
4,789,276 Added 150.55%
7,970,511 $53 Million
Q3 2022

Nov 10, 2022

SELL
$3.9 - $5.52 $17,230 - $24,387
-4,418 Reduced 0.14%
3,181,235 $12.7 Million
Q2 2022

Aug 12, 2022

BUY
$3.89 - $6.44 $342 - $566
88 Added 0.0%
3,185,653 $15.8 Million
Q1 2022

May 13, 2022

BUY
$6.04 - $12.23 $24,776 - $50,167
4,102 Added 0.13%
3,185,565 $19.2 Million
Q4 2021

Feb 14, 2022

SELL
$11.32 - $18.02 $270,898 - $431,236
-23,931 Reduced 0.75%
3,181,463 $37 Million
Q3 2021

Nov 15, 2021

SELL
$12.24 - $20.38 $4.35 Million - $7.25 Million
-355,797 Reduced 9.99%
3,205,394 $50.3 Million
Q2 2021

Aug 13, 2021

BUY
$18.65 - $38.78 $66.4 Million - $138 Million
3,561,191 New
3,561,191 $66.4 Million

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $1.12B
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.